Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer
Apply
GT103 & Pembrolizumab
GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step